arrow
F

Fernanda Herrera

centre hospitalier universitaire vaudois
H指数:24
被引数:2,647

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Challenges in the use of the European Society for Radiotherapy and Oncology–European Organisation for Research and Treatment of Cancer oligometastatic disease classification system in ovarian cancer

使用欧洲放射肿瘤学会–欧洲癌症研究和治疗组织寡转移性疾病分类系统在卵巢癌中的挑战

2026-08-240
PRE
A phase I dose escalation of FLASH radiotherapy in patients with cutaneous metastases from melanoma: The IMPulse trial
2026-01-310
PRE
Progression free survival as a surrogate of overall survival in metastatic or recurrent endometrial cancer: an EORTC Gynaecologic Cancer Group study

无进展生存期作为晚期或复发性子宫内膜癌总生存期的替代指标:一项EORTC妇科肿瘤组研究

2025-08-190
PRE
Updates on radiotherapy-immunotherapy combinations: Proceedings of 8th Annual ImmunoRad Conference

放射治疗-免疫治疗联合疗法的最新进展:第8届年度免疫放射大会会议录

2025-05-220
OAAI
Average Dose Rate is the Major Temporal Beam Structure Parameter for Preserving Murine Intestines With Pulsed Electron FLASH Radiation Therapy

Grilj, V.; Zayas, A.V.; Sesink, A.; Devanand, P.; Repáraz, D.; Paisley, R.; Sprengers, K.; Passelli, K.; Pernot, J.; Böhlen, T.T.;等. 脉冲电子FLASH-RT中平均剂量率是保护小鼠肠道的主要时间束流结构参数. 国际放射肿瘤学杂志, 2025, 2025, S036030162500389X. [Google Scholar] [CrossRef]

2025-05-020
PRE
Pushing the boundaries of radiotherapy-immunotherapy combinations: highlights from the 7th immunorad conference

推动放射疗法-免疫疗法组合的界限: 第7届immunorad会议的亮点

2024-12-180
OAAI
Hybrid ultra-high and conventional dose rate treatments with electrons and photons for the clinical transfer of FLASH-RT to deep-seated targets: A treatment planning study

使用电子和光子的混合超高和常规剂量率治疗,用于将flash-rt临床转移到深层目标: 一项治疗计划研究

2024-12-010
PRE
Response to tumor-infiltrating lymphocyte adoptive therapy is associated with preexisting CD8+ T-myeloid cell networks in melanoma

对肿瘤浸润淋巴细胞过继治疗的反应与黑色素瘤中预先存在的CD8 T髓样细胞网络有关

2024-02-0216
OA
Updates on radiotherapy-immunotherapy combinations: Proceedings of 6th annual ImmunoRad conference
2023-06-216
OA